Biomarker discovery and development in multiple sclerosis: where are we now?

Written by Sharon Salt (Editor)

Robert Fox is a staff neurologist at the Mellen Center for Multiple Sclerosis at the Cleveland Clinic (OH, USA), which is now one of the largest and most comprehensive programs for multiple sclerosis (MS) care and research worldwide. In this interview, Robert speaks to us about serum neurofilament light (sNfL) as a blood biomarker for MS. He also speaks to us about the key advances of biomarker discovery and development in MS, including what the challenges involved with developing biomarkers are for this field. What is your current research focus and what inspired you to work in the field? My...

To view the full article, please register now for access

It's completely free